Performance measures in million hearts: 2 partners' perspective.
Center for Innovative Care, Mercy Health, St. Louis, MO, USA. Joseph.Drozda@Mercy.net
Joseph P
JP
Drozda
David P
DP
Holmes
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D023381:Endpoint Determination; D019317:Evidence-Based Medicine; D006291:Health Policy; D006293:Health Promotion; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D015994:Incidence; D009313:National Health Programs / Q000331:legislation & jurisprudence; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011314:Preventive Health Services / Q000331:legislation & jurisprudence; D011379:Prognosis; D016730:Program Development; D011634:Public Health / Q000331:legislation & jurisprudence; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D016540:Smoking Cessation; D014481:United States; D015431:Weight Loss
D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin